Gentronix
Emma joined Gentronix in 2016 and is currently a Study Director for bacterial reverse mutation (Ames Test) assays. She is an experienced genetic toxicologist having worked for >25 years in GLP-compliant laboratories carrying out genetic toxicology assays including cytogenetic assays, the bacterial reverse mutation assay (Ames test), mammalian gene mutation and Comet assay endpoints.
This person is not in any offices
Gentronix
Gentronix provides services for the development of drugs and other chemicals in the cosmetics and personal care sectors.